Zeranol

Subscribe to Selected New Research on Zeranol

46 relevant articles (1 outcomes, 6 trials/studies) found for this Bio-Agent

Description: A non-steroidal estrogen analog.

Also Known As:

P-1496; P1496; Ralgro; Ralone; Xeranol; Zearanol; P 1496; Dihydroxyundecyl Resorcylic Acid Lactone; Zearalanol; 1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-, (3S-(3R*,7S*))-

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Experts

1.	Tsubura, Airo: 1 article (12/2006)
2.	Tsukamoto, Reiko: 1 article (12/2006)
3.	Yuri, Takashi: 1 article (12/2006)
4.	Miki, Katsuaki: 1 article (12/2006)
5.	Uehara, Norihisa: 1 article (12/2006)
6.	Matsuoka, Yoichiro: 1 article (12/2006)
7.	Yu, Yue: 1 article (11/2004)
8.	Zhao, Xiaoyuan: 1 article (11/2004)
9.	Duan, Jinhong: 1 article (11/2004)
10.	Zuo, Pingping: 1 article (11/2004)

Related Diseases

1.	Weight Gain 03/01/1984 - "Zeranol implants did not significantly affect marketing-transit weight changes, but increased (P less than .05) daily weight gains at all time periods in both trials" 04/01/1983 - "In a trial to determine the effect of zeranol implants on weight gains from birth to 180 days of age, 269 male Holstein calves were assigned randomly to one of three groups: a) 56 intact calves, b) 106 castrated calves implanted at birth and again at 90 days with 36 mg zeranol, and c) 107 castrated controls" 04/01/1994 - "Effects of zeranol implanted during a postweaning weight gain test on testicular, semen, and endocrine characteristics of bulls." 12/01/1989 - "Zeranol increased daily live weight gain and feed conversion in animals in continuous growth as well as in those observed in compensatory growth an tended to eliminate a tendency for higher content of fat in carcasses of nonimplanted animals making compensatory growth." 12/01/1989 - "The effect of zeranol on live weight gain, feed intake and carcass composition of steers during compensatory growth." Get all the results and reference details, order at left...
2.	Body Weight (Weight, Body) 11/01/2004 - "RESULTS: Zeranol did not affect body weight gain" 11/01/2004 - "MATERIALS AND METHODS: Prepubertal female Sprague-Dawley rats were treated daily with either 0, 0.1 or 10 mg/kg body weight of zeranol between 15 and 19 days of age" 04/01/2001 - "ANIMALS: 6,096 crossbred yearling steers with a mean (+/- SD) body weight of 377.0 (+/- 37) kg. PROCEDURE: Steers were implanted with zeranol and alternately separated to fill each of 24 pens" 04/01/1994 - "Implantation with zeranol did not affect body weight or hip weight at day 140 or carcass weight at slaughter" 01/01/1981 - "Zeranol implants have been shown to increase body weight of animals group II and III. A significant difference was found in the number of the pars distalis cells as well as the histochemical changes in their properties have been observed in zeranol implanted lambs" Get all the results and reference details, order at left...
3.	Postmenopausal Osteoporosis 09/01/1997 - "Thus, for the first time, the bioactivity of coumestrol and zearalanol in preventing bone loss has been demonstrated in a well-recognized model of postmenopausal bone loss." 09/01/1997 - "To examine a potential role for phytoestrogens in postmenopausal bone loss, the oophorectomized (OOX) rat model has been used in three studies to investigate the effects of the phytoestrogens coumestrol, zearalanol and a mixture of isoflavones on estrogen-dependent bone loss" Get all the results and reference details, order at left...
4.	Liver Neoplasms (Liver Cancer) 02/01/1992 - "Because zeranol is acting alone as a primary initiator of hepatic neoplasms, this model provides an unusual opportunity to study the pathogenesis of estrogen-initiated tumorigenesis." Get all the results and reference details, order at left...
5.	Carcinoma (Carcinomatosis) 12/01/2006 - "Thus, zeranol exerted dose-dependent biphasic effects on ER-positive human breast carcinoma cells, accelerating cell growth at low concentrations and inducing apoptosis at high concentrations." 12/01/2006 - "At high concentrations, zeranol suppressed the growth of both ER-positive and -negative human breast carcinoma cells" 12/01/2006 - "At low concentrations, zeranol accelerated the growth of ER-positive MCF-7 and KPL-1 human breast carcinoma cells, but did not affect the growth of ER-negative MDA-MB-231 cells" 12/01/2006 - "In the present study, we investigated the effects of zeranol on the growth of estrogen receptor (ER)-positive and -negative human breast carcinoma cells in vitro, and the molecules involved" 12/01/2006 - "Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells." Get all the results and reference details, order at left...
19 Diseases and 46 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	RNA (Ribonucleic Acid)
2.	DNA (Deoxyribonucleic Acid)
3.	Cathepsin D
4.	Estrogens (Estrogen)
5.	Phytoestrogens (Phytoestrogen)
6.	Methoxychlor (Metox)
7.	Isoflavones
8.	Coumestrol
9.	bisphenol A
10.	Estradiol (Estrace)
30 Drugs and Important Bio-Agents and 28 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Castration
1 Therapies and Procedures and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>